Société Entasis Therapeutics Holdings Inc.
Actions
ETTX
US2936141033
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 51
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01/05/15 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/15 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 63 | 04/11/19 |
Kyle Dow
IRC | Investor Relations Contact | - | - |
Matthew Ronsheim
PRN | Corporate Officer/Principal | 52 | 01/09/20 |
Anna Diaz Triola
PRN | Corporate Officer/Principal | - | 19/07/21 |
John Mueller
PRN | Corporate Officer/Principal | 64 | 01/05/15 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Hastings
BRD | Director/Board Member | 62 | 01/04/18 |
Director/Board Member | 58 | 01/08/17 | |
Heather Behanna
BRD | Director/Board Member | 49 | 01/08/17 |
David Meek
CHM | Chairman | 59 | 24/06/19 |
Marianne Zhen
BRD | Director/Board Member | 55 | 11/07/22 |
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01/05/15 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 11/07/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 47 851 779 | 44 441 302 ( 92,87 %) | 0 | 92,87 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31 % | 103 Md | |
+0,56 % | 95,71 Md | |
+1,69 % | 22,02 Md | |
-17,37 % | 20,9 Md | |
-9,30 % | 17,85 Md | |
-41,01 % | 16,21 Md | |
-14,85 % | 15,52 Md | |
+3,21 % | 13,86 Md | |
+33,54 % | 12,04 Md |